![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
SYNTAX II Trial: Introduction to Rationale (Boston Scientific Cardiology) View |
![]() |
SYNTAX II Trial: Role of Assessment in Multivessel Disease (Boston Scientific Cardiology) View |
![]() |
SYNTAX II: 3 Year Outcome Results (Boston Scientific Cardiology) View |
![]() |
EuroPCR 2018: SYNTAX II - Prof Patrick Serruys (Radcliffe Cardiology) View |
![]() |
SYNTAX trial influence in the USA (SCTS Education) View |
![]() |
SYNTAX trial 5 year results (SCTS Education) View |
![]() |
AP English Language: Introduction to Syntax (Marco Learning) View |
![]() |
CABG is the best therapy for coronary artery disease (SCTS Education) View |
![]() |
TCT 2022: FAME 3: FFR-Guided PCI Vs CABG in Pts With Multivessel CAD | Dr Yuhei Kobayashi (Radcliffe Cardiology) View |
![]() |
2. Update on Left Main Revascularization: The Interventionalist’s Perspective : Jean-François Gobeil (Montreal Live Symposium) View |